Shire 'looking' at Salix

Discussion in 'Shire' started by Anonymous, Nov 18, 2014 at 1:28 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    Two little turd companies combine to make one big shit company!
    Who cares anyway?
     

  2. Anonymous

    Anonymous Guest

    We should be very aggressive here. Easy to mock Salix since we compete in the 5-ASA space and have destroyed them. That said, Apriso makes up a tiny fraction of their business and their pipeline blows ours out of the water. Their antibiotic alone makes this a no-brainier. Solidifies our position in GI. Lialda goes generic soon- what then?
     
  3. Anonymous

    Anonymous Guest

    Salix is too reliant on xiafaxan. Going forward I see strong headwinds from hcv oral therapys plus i do not see pcp's and Im's writing it for Ibs D (not gonna happen).
    The other products are junk and the reps are cheeser cheesers
    VOTE NO
     
  4. Anonymous

    Anonymous Guest

    You have no idea what you're talking about.
     
  5. Anonymous

    Anonymous Guest

    Yeah right like a shareholder gives a shit what you think. Vote No. What a dipshit you are.
     
  6. Anonymous

    Anonymous Guest

    Word out of Chesterbrook is that Salix is asking for north of $170 per share. Shire will not pursue.
     
  7. Anonymous

    Anonymous Guest

    Of course they are looking at North of 170. That's a no brainer...
     
  8. Anonymous

    Anonymous Guest

    Valeant starts at 150. What say you Shire? Clock is ticking.
     
  9. Anonymous

    Anonymous Guest

    FO would have to man up and won't be able to push Pearson around. We are way outclassed vs Valeant.
     
  10. Anonymous

    Anonymous Guest

    Shire is putting a bid for Salix
     
  11. Anonymous

    Anonymous Guest

    Both Valeant and Shire leaking articles on the same day. This is going to get interesting!
     
  12. Anonymous

    Anonymous Guest

    Or more likely Salix leaked both articles trying to get a higher price. You can't trust anything that company says- they already had the CEO and CFO get fired for false financials. They will be had on the cheap no one is going overpay for them.
     
  13. Anonymous

    Anonymous Guest

    Do a little reading. There were no 'faked' financials. No past restatements occurred. You simply spouted off what the initial 'drive by' articles stated. Abnormally high wholesaler inventory was the only issue.
     
  14. Anonymous

    Anonymous Guest

    Now Salix is worth more than BEFORE the 'scandal'!